Covered recipient · General Payments record
JULIAN M VASSAY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,343.96
- Reported across 319 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $534.20 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $141.10 | 8 |
| Amgen Inc. | $134.53 | 10 |
| Novo Nordisk AS | $87.49 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $48.88 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40.51 | 2 |
| Insulet Corporation | $37.41 | 1 |
| PFIZER INC. | $29.73 | 2 |
| E.R. Squibb & Sons, L.L.C. | $14.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $12.82 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732300 | CMS |
| Amgen Inc. | $12.98 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732302 | CMS |
| Amgen Inc. | $11.71 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732304 | CMS |
| Amgen Inc. | $14.89 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732306 | CMS |
| Amgen Inc. | $12.49 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117405768 | CMS |
| Amgen Inc. | $12.32 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732308 | CMS |
| Amgen Inc. | $14.02 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732298 | CMS |
| Amgen Inc. | $16.47 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117405770 | CMS |
| Amgen Inc. | $11.70 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732310 | CMS |
| Amgen Inc. | $15.13 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117405772 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.76 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117834628 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.75 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117834630 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.55 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101479573 | CMS |
| Insulet Corporation | $37.41 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116796099 | CMS |
| Lilly USA, LLC | $24.94 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135088997 | CMS |
| Lilly USA, LLC | $11.08 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135075347 | CMS |
| Lilly USA, LLC | $17.67 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135112714 | CMS |
| Lilly USA, LLC | $18.43 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135075349 | CMS |
| Lilly USA, LLC | $19.60 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135112716 | CMS |
| Lilly USA, LLC | $18.29 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135075351 | CMS |
| Lilly USA, LLC | $13.62 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135088999 | CMS |
| Lilly USA, LLC | $17.47 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135112718 | CMS |
| Novartis Pharmaceuticals Corporation | $24.74 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087404194 | CMS |
| Novartis Pharmaceuticals Corporation | $24.14 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087404208 | CMS |
| Novo Nordisk Inc | $16.03 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097440642 | CMS |
| Novo Nordisk Inc | $15.42 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097556818 | CMS |
| Novo Nordisk Inc | $16.19 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096929596 | CMS |
| Novo Nordisk Inc | $23.94 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097427703 | CMS |
| Novo Nordisk Inc | $15.91 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097129112 | CMS |
| PFIZER INC. | $14.82 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131266765 | CMS |
| PFIZER INC. | $14.91 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131746376 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.